Q3 2021 Holdings
Filed 2021-11-12 | 265 holdings | $1.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $297.1M | 983,938 | 17.1% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $265.9M | 1,408,418 | 15.3% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $200.4M | 4,341,992 | 11.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $184.2M | 2,241,403 | 10.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $149.1M | 527,000 | 8.6% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $128.7M | 2,967,127 | 7.4% |
| Align Technology Inc(ALGN) | COM | 016255101 | $104.5M | 157,031 | 6.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $71.9M | 1,154,545 | 4.1% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $53.3M | 612,821 | 3.1% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $45.4M | 1,336,023 | 2.6% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $34.3M | 46,015 | 2.0% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $30.5M | 282,900 | 1.8% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $29.3M | 3,463,000 | 1.7% |
| Atricure Inc(ATRC) | COM | 04963C209 | $29.1M | 418,016 | 1.7% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $26.1M | 63,329 | 1.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $24.8M | 752,945 | 1.4% |
| Avantor Inc(AVTR) | COM | 05352A100 | $21.0M | 512,216 | 1.2% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $8.3M | 23,000 | 0.5% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $4.0M | 51,700 | 0.2% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $3.5M | 12,700 | 0.2% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $3.3M | 94,700 | 0.2% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $2.7M | 65,700 | 0.2% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $2.1M | 47,200 | 0.1% |
| Caredx Inc(CDNA) | COM | 14167L103 | $2.0M | 30,943 | 0.1% |
| Arcturus Therapeutics Hldgs(ARCT) | COM | 03969T109 | $1.6M | 34,500 | 0.1% |
| Cellectis S A(CLLS) | SPON ADS | 15117K103 | $1.0M | 82,500 | 0.1% |
| Moderna Inc(MRNA) | COM | 60770K107 | $664.8K | 1,727,349 | 0.0% |
| Carmax Inc(KMX) | COM | 143130102 | $365.0K | 2,850 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $319.5K | 1,761,616 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $313.5K | 9,347,926 | 0.0% |
| Constellation Brands Inc(STZ) | CL A | 21036P108 | $307.0K | 1,459 | 0.0% |
| Costar Group Inc(CSGP) | COM | 22160N109 | $301.0K | 3,500 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $288.1K | 3,004,051 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $203.4K | 2,957,000 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $202.4K | 203,595 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $191.9K | 3,238,036 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $178.9K | 8,544,597 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $177.2K | 475,210 | 0.0% |
| Abbott Labs(ABT) | COM | 002824100 | $163.9K | 1,387,499 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $144.3K | 263,839 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $142.2K | 3,209,004 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $140.7K | 3,773,919 | 0.0% |
| Danaher Corporation(DHR) | COM | 235851102 | $139.0K | 456,679 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $132.1K | 337,982 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $129.5K | 5,769,039 | 0.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $123.5K | 1,034,519 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $121.7K | 312,762 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $118.4K | 3,755,962 | 0.0% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $112.0K | 455,572 | 0.0% |
| Stryker Corporation(SYK) | COM | 863667101 | $111.4K | 422,332 | 0.0% |